Form 4: Hims & Hers CEO Dudum Reports RSU Vesting, Tax Withholding

Hims & Hers Health, Inc. CEO Andrew Dudum reported the vesting and settlement of restricted stock units and associated tax withholdings of Class A Common Stock.

Summary

• Andrew Dudum, CEO, Director, and 10% Owner of Hims & Hers Health, Inc., reported transactions on March 13, 2026.
• Disposed of 436,190 shares of Class A Common Stock at $24.77 to cover tax withholding obligations related to vested performance restricted stock units.
• Acquired 164,369 shares of Class A Common Stock through the settlement of restricted stock units (RSUs).
• Disposed of an additional 90,296 shares of Class A Common Stock at $24.77 to cover tax withholding obligations related to RSU vesting and settlement.
• Direct beneficial ownership of Class A Common Stock after these transactions is 1,310,617 shares.
• Indirect beneficial ownership of Class A Common Stock is held across several trusts, totaling 8,217,937 shares.
• Several tranches of Restricted Stock Units (RSUs) vested and settled, converting to Class A Common Stock, with remaining RSUs still subject to vesting schedules.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine insider transactions related to executive compensation, specifically RSU vesting and tax withholdings, which are standard and do not indicate any significant positive or negative operational or strategic developments.

Positives

• The vesting of Restricted Stock Units indicates continued long-term incentive alignment between the CEO and shareholder interests.
• The acquisition of 164,369 shares through RSU settlement increases the CEO's direct beneficial ownership, demonstrating confidence.

Negatives

• The disposition of 526,486 shares (436,190 + 90,296) to cover tax withholding obligations represents a reduction in direct shareholding, although this is a standard practice for RSU vesting.

Future Outlook

The filing details future vesting schedules for various tranches of Restricted Stock Units, indicating ongoing equity compensation for the CEO tied to service-based requirements over a four-year period, with quarterly installments on specified dates.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and associated tax withholdings, are common in the healthcare and wellness technology sector, reflecting standard executive compensation practices. These transactions typically do not signal a change in strategic direction or operational performance.

Stakeholder Impact

• Shareholders: The transactions reflect standard executive compensation practices and do not immediately suggest a material change in company value or strategy. The disposition of shares for tax purposes is a common occurrence and not necessarily a signal of lack of confidence.
• Employees: The RSU vesting structure is a common form of long-term incentive, aligning executive interests with company performance over time.

Next Steps

• Continued vesting of remaining Restricted Stock Units in substantially equal quarterly installments on Company Quarterly Vesting Dates (March 15, June 15, September 15, December 15) over a four-year period.

Key Dates

Keywords

Hims & Hers Health, HIMS, Andrew Dudum, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, CEO Stock Ownership, Equity Compensation